LA Times 9/23/14: U.S. doctor was treated with experimental Ebola drug TKM-Ebola. An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firm Tekmira, on Sept. 5, the day he arrived at Nebraska Medical Center in Omaha, hospital officials said in a statement. The drug, which is designed to stop the Ebola virus from replicating, was administered to Sacra over seven days.

KETV Omaha 9/23/14: Nebraska Medical Center doctors reveal Ebola drug used on Dr. Sacra. The team of doctors treating the third American infected with the deadly Ebola virus have revealed the experimental drug used in treating him.
Dr. Rick Sacra, who arrived at the Nebraska Medical Center’s biocontainment unit in early September, is using a drug called TKM-Ebola.

New York Daily News 9/23/14: Richard Sacra, third American missionary with Ebola, being treated with Canadian experimental drug. Dr. Richard Sacra, the third American missionary to contract Ebola while serving in West Africa, is being treated with an experimental drug called TKM-Ebola. The treatment, made by Canada’s Tekmira Pharmaceuticals, has been approved by regulators for emergency use, though the Food and Drug Administration has yet to approve it in totality. Sacra received the drug at Nebraska Medical Center and is doing well, according to the hospital.